Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
VRTXVertex Pharmaceuticals
FinDog View：Neutral
| Metric | TMO | VRTX |
|---|
| Close | 648.43 | 513.26 |
| Market Cap | $240B | $121B |
| 1M | +10.75% | −0.44% |
| P/E (TTM) | 34.4 | 29.7 |
| Forward P/E | 21.8 | 24.0 |
| P/E 5-Yr Percentile | 65 | 52 |
| P/S | 5.2 | 10.4 |
| P/B | 4.6 | 6.5 |
| Dividend Yield | 0.29% | — |
| Latest Quarter Revenue | $12.0B | $3.3B |
| Revenue YoY | +10.5% | +12.5% |
| Gross Margin | — | 85.3% |
| Latest Quarter EPS | 4.68 | 4.31 |
| Avg Post-Earnings Move | ±1.2% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.36% | 1.66% |
| 90-Day Net Insider Buying | −$38.9M | −$2.8M |
TMO · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
